Advertisement

The T-Lymphocyte Response to Varicella-Zoster Viral Proteins

  • Ann M. Arvin
  • Celine M. Koropchak
  • Margaret Sharp
  • Randy Bergen
  • Pamela S. Diaz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 278)

Abstract

The importance of cellular immunity in the host’s response to varicella-zoster virus (VZV) is manifested clinically by the severity of varicella in children with congenital or acquired T-cell deficiencies (1). The frequent occurrence of herpes zoster with suppression of cellular immunity implies that such immunity is also required to prevent symptoms due to viral reactivation. When a VZV antigen preparation made from sonicated infected cells was used to stimulate T lymphocytes, the early acquisition of VZV-specific T-cell proliferation was found to correlate with mild primary VZV infection, the absence of VZV cellular immunity was associated with progressive varicella, and diminished VZV T-cell immunity defined periods of susceptibility to recurrent VZV in patients with malignancy (2–5). In contrast, immunoglobulin deficiencies have not been associated with severe primary VZV disease, and VZV IgG antibody titers are not usually low at the onset of herpes zoster.

Keywords

Herpes Simplex Virus Herpes Zoster Cellular Immunity Vaccinia Recombinant Varicella Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pinkel, D. (1961) J. Pediatr. (St. Louis) 58, 729–732.Google Scholar
  2. 2.
    Arvin, A. M., Koropchak, C. M., Williams, B. R. G. and Grumet, F. C. (1986) J. Infect. Dis. 154, 422–429.PubMedCrossRefGoogle Scholar
  3. 3.
    Patel, P. A., Yoonessi, S., O’Malley, J., Freeman, A., Gershon, A. and Ogra, P. L. (1979) J. Pediatr. (St. Louis) 94, 223–230.Google Scholar
  4. 4.
    Miller, A. (1980) Neurology 30, 582–589.PubMedGoogle Scholar
  5. 5.
    Arvin, A. M., Rasmussen, L. E., Pollard, R. B. and Merigan, T. C. (1978) J. Clin. Invest. 65, 869–878.CrossRefGoogle Scholar
  6. 6.
    Arvin, A. M., Kinney-Thomas, E., Shriver, K., Grose, C., Koropchak, C. M., Scranton, E., Wittek, A. E. and Diaz, P. S. (1986) J. ImmunoL 137, 1346–1351.PubMedGoogle Scholar
  7. 7.
    Felser, J. M., Kinchington, P. R., Inchauspe, G., Straus, S. E. and Ostrove, J. M. (1988) J. ViroL 62, 2076–2082.PubMedGoogle Scholar
  8. 8.
    Davison, A. J. and Scott, J. E. (1986) J. Gen. ViroL 67, 1759–1816.PubMedCrossRefGoogle Scholar
  9. 9.
    McGeoch, D. J. and Davison, A. J. (1986) Nucleic Acids Res. 10, 428–436.Google Scholar
  10. 10.
    Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T. and Isomura, S. (1974) Lancet 2, 1288–1290.PubMedCrossRefGoogle Scholar
  11. 11.
    Gershon, A. A., Steinberg, S., Gelb, L., Galasso, G., Borkowsky, W., LaRussa, P. and Ferrara, A. (1984) JAMA 252, 355–362.PubMedCrossRefGoogle Scholar
  12. 12.
    Weibel, R. E., Neff, B. J., Kuter, B. J., Guess, H. A., Rothenberger, C. A., Fitzgerald, A. J., Connor, K. A., McLean, A. A., Hilleman, M. R., Buynak, E. B. and Scolnick, E. M. (1984) N. Engl. J. Med 310, 1409–1415.PubMedCrossRefGoogle Scholar
  13. 13.
    Gershon, A. A., Steinberg, S. P., La Russa, P., Ferrara, A., Hammerschlag, M., Gelb, L. and NIAID Varicella Vaccine Collaborative Study Group (1988) J. Infect. Dis. 158, 132–137.CrossRefGoogle Scholar
  14. 14.
    Diaz, P. S., Smith, S., Hunter, E. and Arvin, A. M., (1988) J. Infect. Dis. 158, 1245–1252.PubMedCrossRefGoogle Scholar
  15. 15.
    Bergen, R. E., Diaz, P. S. and Arvin, A. M. (1989) 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, September, 1989, Abstract 570 (abstracts published by ASM, Washington, D.C.).Google Scholar
  16. 16.
    Margalit, H., Spouge, J. L., Cornette, J. L., Cease, K. B., DeLisi, C. and Berzofsky, J. A. (1987) J. ImmunoL 138, 2213–2224.PubMedGoogle Scholar
  17. 17.
    Rothbard, J. B. (1986) Ann. Inst. Pasteur Paris 137E, 518–525.CrossRefGoogle Scholar
  18. 18.
    Rothbard, J. B. and Taylor, W. R. (1988) EMBO J. 7, 93–100.PubMedGoogle Scholar
  19. 19.
    Erickson, B. W. and Merrifield, R. B. (1976) in The Proteins, eds. Neurath, H. and Hill, R. L. (Academic Press, New York), Vol. 2, pp. 255–527.Google Scholar
  20. 20.
    Diaz, P. D., Smith, S., Hunter, E. and Arvin, A. M. (1988) J. Immunol. 142, 636–641, 1988.Google Scholar
  21. 21.
    Borysiewicz, L. K., Graham, S., Hickling, J. K., Mason, P. D. and Sissons, J. G. P. (1988) Eur. J. Immunol. 18, 269–275.PubMedCrossRefGoogle Scholar
  22. 22.
    Martin, S., Courtney, R. J., Fowler, G. and Rouse, B. T. (1988) J. Virol. 62, 2265–2273.PubMedGoogle Scholar
  23. 23.
    McMichael, A. H., Michie, C. A., Gotch, F. M., Smith, G. L. and Moss, B. (1986) J. Gen. Virol. 67, 719–730.PubMedCrossRefGoogle Scholar
  24. 24.
    Murray, R. J., Young, L. S., Calender, A., Gregory, C. D., Rowe, M., Lenoir, G. M. and Rickinson, A. B. J. ViroL. 62, 894–901.Google Scholar
  25. 25.
    Fazekas de St. Groth, S. (1982) J. Immunol. Methods 49, 1211–1223.Google Scholar
  26. 26.
    Weigle, K. A. and Grose, C. (1984) J. Infect Dis. 149, 741.PubMedCrossRefGoogle Scholar
  27. 27.
    Palumbo, P. E., Arvin, A. M., Koropchak, C. M. and Wittek, A. E. (1984) J. Gen. Virol. 65, 2141–2147.PubMedCrossRefGoogle Scholar
  28. 28.
    Gotch, F., McMichael, A., Smith, G. and Moss, B. (1987) J. Exp. Med. 165, 408–416.PubMedCrossRefGoogle Scholar
  29. 29.
    Thorley-Lawson, D. A., Chess, L. and Strominger, J. L. (1977) J. Exp. Med 146, 495–508.PubMedCrossRefGoogle Scholar
  30. 30.
    Hickling, J. K., Borysiewicz, L. K. and Sissons, J. G. P. (1987) J. Virol. 61, 3463–3469.PubMedGoogle Scholar
  31. 31.
    Yasukawa, M. and Zarling, J. M. (1984) J. Immunol. 133, 422–433.PubMedGoogle Scholar
  32. 32.
    Schmid, D. S. (1988) J. Immunol. 140, 3610–3616.PubMedGoogle Scholar
  33. 33.
    Hayward, A. R., Pontesilli, O., Herberger, M., Laszlo, M. and Levin, M. (1986) J. ViroL 58, 179–184.PubMedGoogle Scholar
  34. 34.
    Lindsley, M. D., Torpey, D. J., III and Rinaldo, C. R., Jr. (1986) J. Immunol. 136, 3045–3051.PubMedGoogle Scholar
  35. 35.
    Hayward, A., Boylston, A. and Beverley, P. (1988) Immunology 64, 87.PubMedGoogle Scholar
  36. 36.
    Yasukawa, M. and Zarling, J. M. (1985) J. Immunol. 134, 2679–2682.PubMedGoogle Scholar
  37. 37.
    Zarling, J. M., Moran, P. A., Burke, R. L., Pachl, C., Berman, P. W. and Lasky, L. (1986) J. Immunol. 136, 4667–4673.Google Scholar
  38. 38.
    Moss, B. and Flexner, C. (1987) Annu. Rev. Immunol. 5, 305.PubMedCrossRefGoogle Scholar
  39. 39.
    Meignier, B., Longnecker, R., Mavromara-Nazos, P., Sears, A. E. and Roizman, B. (1988) Virology 162, 251–259.PubMedCrossRefGoogle Scholar
  40. 40.
    Stanberry, L. R., Bernstein, D. I., Burke, R. L., Pachl, C. and Myers, M. G. (1987)J. Infect. Dis. 155, 914–920.Google Scholar
  41. 41.
    Townsend, A., Rothbard, J., Gotch, F., Bahadut, B., Wraith, D. and McMichael, A. (1986) Cell (Cambridge, Mass.) 44, 959–968.CrossRefGoogle Scholar
  42. 42.
    Yewdell, J. W., Bennick, J. R. and Hosaka, Y. (1988) Science (Washington, D.C., 1883-) 239, 637–640.CrossRefGoogle Scholar
  43. 43.
    Whitton, J. L., Gebhard, J. R., Lewicki, H. and Oldstone, M. B. A. (1988) J. ViroL 62, 687–695.PubMedGoogle Scholar
  44. 44.
    Livingston, A. and Fathman, G. (1987) Annu. Rev. Immunol. 5, 477–493.CrossRefGoogle Scholar
  45. 45.
    DeFreitas, E. C., Dietzschold, B. and Koprowski, H. (1985) Proc. Natl. Acad Sci. USA 82, 3425–3432.PubMedCrossRefGoogle Scholar
  46. 46.
    Eisenberg, R. J., Cerini, C. P., Heilman, C. J., Joseph, B., Dietzschold, B., Golub, E., Long, M., Ponce de Leon, M. and Cohen, G. H. (1985) J. Virol. 56, 1014–1022.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Ann M. Arvin
    • 1
  • Celine M. Koropchak
    • 1
  • Margaret Sharp
    • 1
  • Randy Bergen
    • 1
  • Pamela S. Diaz
    • 1
  1. 1.Department of Pediatrics, Infectious Diseases DivisionStanford University School of MedicineStanfordUSA

Personalised recommendations